MedPath

Use of Sucrose to Relieve Pain During Eye Exams in Infants

Not Applicable
Terminated
Conditions
Apnea of Prematurity
Retinopathy of Prematurity
Pain
Registration Number
NCT00161694
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The purpose of this study is to see if an oral sucrose solution can comfort premature infants during their necessary eye exams. The investigators believe that the use of this solution prior to the eye exams will lead to a decrease in pain as measured by a rise in heart rate and a fall in oxygen saturation. In addition this will lead to a decrease in events in the 12 hours following examination. Events include episodes when the infants temporarily stop breathing, have a drop in their heart rates, or have a drop in their oxygen levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • All premature infants admitted to the Neonatal Intensive Care Unit requiring serial dilated examinations to assess for retinopathy of prematurity will be candidates for this study. This includes all infants with a birthweight of less than 1500 g and infants between 1500 g and 2000 g who require supplemental oxygen.
Read More
Exclusion Criteria
  • Any infant who is unable to safely suckle 0.5 cc of fluid will be excluded from the study. This includes infants that are being maintained on ventilators and those with serious gastrointestinal complications that may be exacerbated by an oral fluid bolus.
  • Any infant being maintained on narcotics for any reason will not be eligible for the study.
  • All infants with major congenital anomalies will be excluded.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYPH - Weill Cornell Medical Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath